Alnylam Pharmaceuticals: Barclays cuts target price to $380 from $450
ALNY•Barclays cut its target price for Alnylam Pharmaceuticals to $380 from $450.
Related News
Barclays raises Mohawk Industries target price to $125 from $115
MHK•
Rupee ends little changed as traders stay cautious despite oil, dollar drop
INDA•
Daewoong Pharma ends Southeast Asia supply deal with Abbott worth KRW 69.23 billion
ABT•
Deutsche Bank raises stake in Bally's Intralot to 1.134%
BALY•
Adhi Kartiko Pratama extends IDR 100 billion Citibank credit facility for one year
C•